Dishman Pharmaceuticals and Chemicals Ltd(Merged)

Next 500 2017
+ 2 More
+ 2 More
OVERVIEW
FINANCIALS

Featured In Fortune India Ranking

#498(2015)
Next 500 India
#8(2017)#88(2015)
#8(2017)#88(2015)
Ranking Trend Fortune Next 500 India

Financial Data 2016

Revenue
1,675
(INR Cr)
Net Operating Income
1,596
(INR Cr)
Assets
2,475
(INR Cr)
Profit
171
(INR Cr)
Net Worth
1,446
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS20162015201420132012201120102009
Revenue
(INR Cr)
1675
-2.5%
1718
19.5%
1438
7.3%
1340
17.3%
1142
6.3%
1074
14.6%
938
-12.0%
1066
-
Net Operating Income
(INR Cr)
1596
0.46%
1589
14.68%
1385
8.89%
1272
13.18%
1124
8.99%
1031
12.67%
915
-13.83%
1062
32.30%
Profit
(INR Cr)
171
42.8%
120
9.7%
109
9.0%
100
76.7%
57
-29.1%
80
-31.8%
117
-19.7%
146
-
Assets
(INR Cr)
2475
10.3%
2244
1.1%
2219
14.4%
1940
2.8%
1887
5.5%
1789
14.8%
1558
9.1%
1428
-
Net Worth
(INR Cr)
1446
17.3%
1232
4.8%
1176
14.3%
1029
11.2%
925
5.9%
874
12.2%
779
11.6%
698
23.3%
Employee Cost
(INR Cr)
535
26.5%
423
2.6%
412
17.5%
351
19.3%
294
4.9%
280
12.4%
249
-6.7%
267
-
Interest Cost
(INR Cr)
9490927973563949
Cash & Bank Balance
(INR Cr)
6236352124434545
Total Debt
(INR Cr)
943933974854850868774724

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS20162015201420132012201120102009
Profit As % Of Revenues 10.2%7.0%7.6%7.5%5.0%7.5%12.5%13.7%
Profit As % Of Assets 6.9%5.3%4.9%5.2%3.0%4.5%7.5%10.2%
Profit As % Of Networth 11.8%9.7%9.3%9.8%6.1%9.2%15.1%21.0%
Interest Cost to EBITDA % 23.0%28.7%27.7%27.2%32.5%27.7%19.1%18.9%
Debt to Equity Ratio 0.650.760.830.830.920.990.991.04
RONW 12.8%10.0%9.9%10.3%6.3%9.7%15.9%23.1%
ROCE 13.9%11.2%12.0%11.7%8.8%8.8%11.6%15.8%